Introduction:Basic information about CAS 83200-10-6|Anipamil, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Anipamil |
|---|
| CAS Number | 83200-10-6 | Molecular Weight | 520.78900 |
|---|
| Density | 0.983g/cm3 | Boiling Point | 641.9ºC at 760 mmHg |
|---|
| Molecular Formula | C34H52N2O2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 342ºC |
|---|
Names
| Name | 2-(3-methoxyphenyl)-2-[3-[2-(3-methoxyphenyl)ethyl-methylamino]propyl]tetradecanenitrile |
|---|
| Synonym | More Synonyms |
|---|
Anipamil BiologicalActivity
| Description | Anipamil is a long-acting calcium channel blocker, used for the treatment of cardiovascular disease. |
|---|
| Related Catalog | Signaling Pathways >>Membrane Transporter/Ion Channel >>Calcium ChannelResearch Areas >>Cardiovascular Disease |
|---|
| In Vivo | Anipamil (40 mg, p.o.)-treated 2K-1C rabbits reveal absent or negligible intimal thickening and a decrease of postnatal-type SMC from the underlying media. Anipamil inhibits the growth of SMC accompanied by the expression of SM-MyHC in all SMC, ie, the appearance of a more differentiated cell phenotype compared to control cultures[1]. In the arrhythmic assay, anipamil (1.0 mg/kg + 0.10 mg/kg/min infusion, n=8 or 5.0 mg/kg + 0.50 mg/kg/min infusion, n=12) reduces VT but not VF[2]. In rats with subtotal (five-sixths) nephrectomy treated with anipamil (0.5 mg/kg/day, p.o.), the mortality is less, and the mean arterial blood pressure is also more well controlled, and the serum creatinine concentration is lower than control group. The anipamil (2 mg/kg/day)-treated group exhibits significantly greater protection of renal function than does the hydralazine-treated group for the same level of blood pressure control[3]. |
|---|
| Animal Admin | Preliminary studies are performed to determine the anipamil dose response. Anipamil is mixed with food to give a dose of 0.5, 2 or 5 mg/kg/day. One week after five-sixths nephrectomy, rats are paired according to renal function, blood pressure and body weight. Rats are then pair-fed and receive either the long-acting calcium channel blocker anipamil (2 mg/kg/day in food, n=20) or placebo (n=20). |
|---|
| References | [1]. Pauletto P, et al. Anipamil prevents intimal thickening in the aorta of hypertensive rabbits through changes in smooth muscle cell phenotype. Am J Hypertens. 1996 Jul;9(7):687-94. [2]. Pugsley MK, et al. Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia. Life Sci. 1995;57(12):1219-31. [3]. Jarusiripipat C, et al. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats. J Pharmacol Exp Ther. 1992 Jan;260(1):243-7. |
|---|
Chemical & Physical Properties
| Density | 0.983g/cm3 |
|---|
| Boiling Point | 641.9ºC at 760 mmHg |
|---|
| Molecular Formula | C34H52N2O2 |
|---|
| Molecular Weight | 520.78900 |
|---|
| Flash Point | 342ºC |
|---|
| Exact Mass | 520.40300 |
|---|
| PSA | 45.49000 |
|---|
| LogP | 8.73088 |
|---|
| Index of Refraction | 1.517 |
|---|
| InChIKey | PHFDAOXXIZOUIX-UHFFFAOYSA-N |
|---|
| SMILES | CCCCCCCCCCCCC(C#N)(CCCN(C)CCc1cccc(OC)c1)c1cccc(OC)c1 |
|---|
Synonyms
| Anipamil |
| Anipamilum |
| Anipamilum [Latin] |
| 2-(3-((m-Methoxyphenethyl)methylamino)propyl)-2-(m-methoxyphenyl)tetradecanenitrile |
| Anipamil [INN] |
| EINECS 280-213-5 |
| Anipamilo |
| Anipamilo [Spanish] |